Silence Therapeutics Plc (SLNCF) Stock Price, News & Analysis
Company Description
Silence Therapeutics Plc (OTC Link: SLNCF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $226.7M.
SLNCF has declined 6.3% over the past year. Shares last traded at $1.50.
For FY2025, Silence Therapeutics Plc reported revenue of $559K with net income of -$88.6M and diluted earnings per share of $-0.63. The company operates at a net profit margin of -15851.5%.
This page collects what Stock Titan holds for SLNCF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Silence Therapeutics Plc (SLNCF) stock last closed at $1.50. Over the past 12 months, the stock has lost 6.3%. At a market capitalization of $226.7M, SLNCF is classified as a micro-cap stock with approximately 141.7M shares outstanding.
SLNCF Rankings
Latest News
Silence Therapeutics Plc has 3 recent news articles. Key topics include management. View all SLNCF news →
SEC Filings
Silence Therapeutics Plc has filed 5 recent SEC filings, including 2 Form 8-K, 1 Form 4, 1 Form 8-K/A, 1 Form SCHEDULE 13D/A. The most recent filing was submitted on July 16, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SLNCF SEC filings →
Financial Highlights
Silence Therapeutics Plc generated $559K in revenue in FY2025, retaining a 61.5% gross margin, operating income reached -$91.1M (-16292.8% operating margin), and net income was -$88.6M, reflecting a -15851.5% net profit margin. Diluted earnings per share stood at $-0.63. The company generated -$62.3M in operating cash flow. With a current ratio of 8.72, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Silence Therapeutics Plc (SLNCF) currently stands at 39 shares. Since January 2026, short interest has decreased by 94.8%.
Days to Cover History
Days to cover for Silence Therapeutics Plc (SLNCF) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 41.9% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
SLNCF Company Profile & Sector Positioning
Silence Therapeutics Plc (SLNCF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing SLNCF often look at related companies in the same sector, including Bioinvent Intern (BOVNF), Hansa Medical AB (HNSBF), Oryzon Genomics (ORYZF), Nervgen Pharma Corp (NGENF), and Adocia (ADOCY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SLNCF's relative position within its industry.